EN
HI

TATVA CHIN PHARM CHEM Share price

TATVA

ChemicalsSmall

769

3.75 (0.49%)
NSE
BSE
Last updated on 16 May, 2025 | 15:31 IST
BUYSELL
Today's High

775.55

Today's Low

760.20

52 Week Low

621.00

52 Week High

1222.00

The current prices are delayed, login to your account for live prices

Tatva Chintan Pharma Chem Chart

TATVA CHIN PHARM CHEM Share Key Metrics

Volume
48964.00
Market Cap
1798.85 CR
LTQ@LTP
1@769.00
ATP
769.69
Var Margin
19.2 %
Circuit Range
612.2-918.3
Delivery %
41.58 %
Value
3.77 CR
ASM/GSM
No
Market Lot
1

TATVA CHIN PHARM CHEM Futures & Options

Data Not Found

TATVA CHIN PHARM CHEM Corporate Actions

DateAgenda
2025-05-02Audited Results & Final Dividend
2025-01-28Quarterly Results
DateEvent TypeAgenda
2025-05-02Board MeetingAudited Results & Final Dividend
2025-01-28Board MeetingQuarterly Results

TATVA CHIN PHARM CHEM News

Tatva Chintan Pharma Chem gets blockbuster debut, lists at 95% premium over issue price

Jul 29 2021 11:30:36

Tatva Chintan Pharma Chem gets blockbuster debut, lists at 95% premium over issue price

Jul 29 2021 11:15:29

Tatva Chintan Pharma Chem Stock to Debut on BSE, NSE Today. Time, Listing Price

Jul 29 2021 08:30:38
Read More

About TATVA CHIN PHARM CHEM

NSE : 5162  
BSE : 543321  
ISIN : INE0GK401011  

The Company was incorporated as ‘Tatva Chintan Pharma Chem Private Limited’ pursuant to a certificate of incorporation dated June 12 1996 issued by the Registrar of Companies Gujarat and Dadra & Nagar Haveli at Ahmedabad (“RoC”). Thereafter pursuant to the conversion of the Company to a public limited company the name of the Company was changed to ‘Tatva Chintan Pharma Chem Limited’ and a fresh certificate of incorporation dated February 26 2021 was issued to the Company by the RoC.Major events and milestones of the Company :1996- Incorporation of the Company2004- Received licence to manufacture for sale (or for distribution) of certain drugs from the Food and Drugs Control Administration Gujarat at the Ankleshwar Manufacturing Facility2007- Expansion of manufacturing capacity at the Ankleshwar Manufacturing Facility2011- Commenced commercial manufacturing of SDAs2013- Attained turnover of Rs. 500.00 million2015- Attained turnover of Rs. 1 billion- Incorporation of Tatva Chintan USA Inc. a wholly owned Subsidiary of the Company- Set up warehousing facility in Netherlands2017- Set up the Dahej Manufacturing Facility2018- Set up R&D facility in Vadodara2019- Incorporation of Tatva Chintan Europe BV a wholly owned Subsidiary of the Company2020- Completion of ‘Together for Sustainability’ audit- Conversion of the Ankleshwar Manufacturing Facility to a ‘zero liquid effluent discharge facility’- Attained total revenue of Rs. 2 billion- Increase in manufacturing capacity at the Dahej Manufacturing Facility resulting in an increase in the aggregate manufacturing capacity of the Company from 160 KL and 10 Assembly Lines to 280 KL and 13 Assembly Lines Awards accreditations or recognitions :2006- Received ISO 9001:2015 certification for the manufacturing facility at Ankleshwar2015- Appreciation certificate from the Office of the Chief Commission of Central Excise Customs & Service Tax Vadodara Zone for the Company’s contribution to the revenue and voluntary compliance with tax laws2016- Accorded the status of a two star export house from the Directorate General of Foreign Trade Ministry of Commerce and Industry Government of India2017- Received ISO 14001:2015 and BS OHSAS 18001:2007 certification for the manufacturing facility at Ankleshwar2018- Received ISO 9001: 2015 certification for manufacturing facilities at Ankleshwar and Dahej- Received ISO 14001: 2015 and BS OHSAS 18001:2007 certification for manufacturing facility at Dahej2019- R&D facility recognized by the Department of Scientific and Industrial Research Government of India for the purpose of availing customs duty exemption2020- Received ISO 14001:2015 and 45001:2018 certification for manufacturing facility at Ankleshwar

TATVA CHIN PHARM CHEM Management

NamePosition
Mr. Chintan Nitinkumar Shah Chairman & Managing Director
Mr. Ajaykumar Mansukhlal Patel Whole Time Director
Mr. Shekhar Rasiklal Somani Whole Time Director
Dr. Manher Chimanlal Desai Independent Director
Mr. Subhash Ambubhai Patel Independent Director
Read More

TATVA CHIN PHARM CHEM FAQs

The Buying Price of TATVA CHIN PHARM CHEM share is 769 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy TATVA CHIN PHARM CHEM share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of TATVA CHIN PHARM CHEM shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio TATVA CHIN PHARM CHEM shares is 2.47. Useful to assess the stock's value relative to its book value.

To assess TATVA CHIN PHARM CHEM’s valuation compare Sector P/E, P/B which are 32.15 & -0.24 with sector averages, along with growth rates and financial metrics.

The Market Cap of TATVA CHIN PHARM CHEM is 1798.85 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of TATVA CHIN PHARM CHEM share price is 1222.00 & 621.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.